Ann: AGM Chairman's Address and Investor Presentation, page-11

exciting times ahead.
is it that the diagnostic test will be used to pre predict a patient to prevent kidney disease and also to measure the outcome of treatment once the patient is on treatment for kidney disease.

it seems like the only sensible and un invasive method of measuring kidney disease outcomes once it has taken hold - am I right in saying that?

if sonic has 2 million diabetics on their data base then it is those patients that will be directing their GP to the test.

I can't see how this doesn't ramp up quickly from here.

once sales are rolling in how does it effect the overheads for PIQ. do their overheads go up as sales go up? how?

surely someone is going to make a lot of money here.

good luck to all shareholders- this could be life changing if you hold enough.